Australia, June 11 -- Amylyx Pharmaceuticals Inc., owns the trademark (2634619) for 'ZABALA' till Feb. 4, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders.] and 05 [Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders]
Type of Mark: Word
Date of Acceptance: April 2
Registration Advertised: June 10
For further details contact Fish & Richardson P.C..
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2634619.
Disclaimer: Curated by HT Syndication.
